Andrew J. Long

Engagement of the Pd-1 Immunoinhibitory Receptor by a Novel B7 Family Member Leads to Negative Regulation of Lymphocyte Activation

Gordon J. Freeman, Andrew J. Long, Yoshiko Iwai et al. · The Journal of Experimental Medicine · 2000 · 5.2K citations · Full text

Life Sciences, Immunology, Pathology +17

PD-L2 is a second ligand for PD-1 and inhibits T cell activation

Yvette Latchman, Clive R. Wood, Tatyana Chernova et al. · Nature Immunology · 2001 · 2.9K citations

Life Sciences, Cell Biology, Immunology +14

In vitro and in vivo characterization of the JAK1 selectivity of upadacitinib (ABT-494)

Julie Parmentier, J W Voss, Candace Graff et al. · BMC Rheumatology · 2018 · 374 citations · Full text

Medicine, Immunology, Pharmacology +16

Characterization of murine Flt4 ligand/VEGF-C

Lori Fitz, John C. Morris, Paul Towler et al. · Oncogene · 1997 · 44 citations

Life Sciences, Molecular Biology, Pharmacology +9

The JAK1 Selective Inhibitor ABT 317 Blocks Signaling Through Interferon-γ and Common γ Chain Cytokine Receptors to Reverse Autoimmune Diabetes in NOD Mice

Tingting Ge, Gaurang Jhala, Stacey Fynch et al. · Frontiers in Immunology · 2020 · 44 citations · Full text

Life Sciences, Immunology, Molecular Biology +17